Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IV Iron Isomaltoside in Bimaxillary Orthognathic Surgery
NCT03094182Unknown
- Sponsor
- Yonsei University
- Start
- Mar 2017
- Primary completion
- Aug 2019
- Modality
- Inorganic Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of ferric derisomaltose in postoperative anemia (2 arms), sponsored by Yonsei University. Primary endpoint: Postoperative Hemoglobin Concentration at 4 weeks. Status: unknown.
02
Drugs
ferric derisomaltose
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on NCT03094182.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03094182.